Results

Total Results: 475 records

Showing results for "gender".

301. S38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
     October 01, 2007 - (%) 37 (17) 42 (20) — *P value based on rank-sum test for ordered characteristics, and �2 test for gender

302. Microsoft Word - ehcrr#2toCSI.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
     August 01, 2007 - Model Mortality ratios (95% CI) Unadjusted analysis of death within 180 days 1.47 (1.39-1.56) Age-gender-calendar

303. Disposition of Comments for Technical Brief 25 Disparities within Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
     May 26, 2016 - differences that arise within that population among disparity subgroups such as a race/ethnicity, age, gender

304. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
     February 01, 2015 - Cooperative Study – activities of daily living scale).12 Secondary analyses of these data demonstrated both gender

305. Revised Protocol - Opioids 12 13 13[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
     December 19, 2013 - , inflammatory pain, and headache disorders); 2) patient demographics (e.g., age, race, ethnicity, gender

306. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - We did however review the full-text of the relevant articles as the reporting of gender- specific outcomes … of trials: 21 noninvasive [ALL-FIELDS] AND coronary artery disease [DISEASE] AND ( NOT "Male" ) [GENDER … Gender differences and prognostic value in the exercise capacity and gated SPECT in patients with suspected

307. Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
     July 01, 2025 - stimulant misuse with subsequent methamphetamine use among a U.S. cohort of HIV-vulnerable sexual and gender … Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019. … Medical, nonmedical, and illegal stimulant use by sexual identity and gender. … Assessing motivations and gender as factors in college students’ views of nonmedical prescription stimulant

308. Behavioral Interventions for Migraine Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bimp-protocol.pdf
     September 27, 2022 - publication, design, authors, purpose, country), patients’ characteristics and settings (e.g., age, sex, gender

309. Treatment of Stage I-III Squamous Cell Anal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
     September 26, 2023 - common type, accounting for over 90 percent of anal malignancies,2-4 and risk factors include female gender

310. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
     March 01, 2012 - analyses from individual included trials was extracted and then analyzed for the subgroups of age, gender … We did look for specific information in each trial by age, gender, and ethnicity. … of the form a question is asked “Does This trial or study have sub group analysis looking at age, gender … They looked at BMI, age, gender, ASA score, comorbidities, medication including the use of steroids

311. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
     March 01, 2010 - Patients) H-ISDN >1 Day (3,829 Patients) p % or Mean % or Mean SOCIO-DEMOGRAPHIC DATA Gender

312. Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-disposition-comments_0_0.pdf
     October 13, 2021 - control for severity of risk for adverse outcomes through stratification of vulnerable patients by age, gender … Studies included had some but limited numbers of sociodemographic factors, such as age, gender and … Similarly, metrics such as BMI fail to account for variations related to gender, age, race, or body

313. Multidisciplinary Rehabilitation Programs for Moderate to Severe Traumatic Brain Injury in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation-future_research.pdf
     January 01, 2013 - Sustainability of Health Outcomes Improvements sustained up to 5 years Patient Characteristics Age, Gender … Sustainability of Health Outcomes Improvements sustained up to 5 years Patient Characteristics Age, Gender

314. Disposition of Comments for Strategies To Prevent Weight Gain Among Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_disposition-comments.pdf
     March 25, 2013 - Similarly, given that gender was examined separately in the Robins et al (2006) study, it would be informative … available data allow) to look at the effectiveness of the strategies with reference to weight status, gender

315. Effects of Dietary Sodium and Potassium Intake on Chronic Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
     April 18, 2017 - meet or exceed the nutrient requirements of almost all individuals in a particular life stage and gender … conduct and report on subgroup analyses to answer the subquestions on subpopulations of interest, i.e., gender

316. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - added text that points to the CIN outcome by characteristics of the study populations, including age, gender … analyses between CIN incidence and each of the following covariates: age, baseline creatinine, diabetes, gender

317. Wireless-Motility-Capsule Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
     May 01, 2013 - of time in between diagnostic tests), characteristics of study participants (e.g., condition; age; gender … others included patients older than 65 years of age.41, 42 Study Population Characteristics No gender

318. Treatment Resistant Depression Surveillance FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
     April 01, 2016 - There was no difference associated with gender, sociodemographic group, education, or medical comorbidity … There was no difference by gender, sociodemographic group, education, or medical comorbidity. 2

319. Treatment of Osteoarthritis of the Knee: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
     June 15, 2016 - factors for osteoarthritis of the knee are aging, obesity, prior injury, repetitive use,4 and female gender … Placebo effects in analgesic medication trials in two chronic pain models: Gender and pain disorder

320. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
     December 31, 2022 - level and duration of detectable SARS-CoV-2 antibodies vary by patient characteristics (e.g., age, gender … level and duration of detectable SARS-CoV-2 antibodies vary by patient characteristics (e.g., age, gender